Below you can find the provisional program of NanoTME 2025. Small adjustments (for example to poster pitching order) may be made close to the conference.
Monday May 5, 2025 | |
9:00-10:00 | Registration and coffee/tea |
10:00-10:15 | Opening |
| Jai Prakash and Yuval Shaked |
Immune Cell-Based Therapies Chair: Yuval Shaked | |
10:15-11:00 | Michele de Palma (Keynote) ANTIGEN AGNOSTIC DENDRITIC CELL THERAPY |
11:00-11:30 | Leila Akkari REFINING MACROPHAGE TARGETING IN THE BRAIN TUMOR MICROENVIRONMENT |
Short talks selected from abstracts (12 min + 3 min discussion) | |
11:30-11:45 | Tamar Gross Lev RESECTED TUMOR BIOMIMETIC NANOPARTICLES FOR PERSONALIZED IMMUNOTHERAPY |
11:45-12:00 | Kati Turkowski EXPLORING THE HETEROGENEITY AND PLASTICITY OF TUMOR-ASSOCIATED MACROPHAGES IN LUNG CANCER: TOWARD TARGETED IMMUNOTHERAPIES |
12:00-13:30 | Lunch |
ECM and Stromal Dynamics Chair: Jai Prakash | |
13:30-14:00 | Neta Erez STROMAL AND IMMUNE PLASTICITY SHAPE THE METASTATIC MICROENVIRONMENT |
14:00-14:30 | Alejandro Mayorca Guiliani MAPPING THE ECM USING MACHINE LEARNING TOOLS |
14:30-15:00 | João Mano IN VITRO TUMOR MICROENVIRONMENT MODELS |
Short talks selected from abstracts (12 min + 3 min discussion) | |
15:00-15:15 | Bar Manobla Induction of BMP1 by activated cytotoxic T cells supports immunotherapy-induced tumor ECM remodeling |
15:15-15:30 | Ana Baião CD44V6-DRIVEN NANOPARTICLES COMBINED WITH IMMUNE THERAPY FOR COLORECTAL CANCER |
15:30-16:00 | Tea/Coffee Break |
Nanoparticle-based Therapy and Genome Editing Chair: Bas van Bochove | |
16:00-16:30 | Dan Peer THERAPEUTIC GENOME EDITING IN CANCER USING CELL SPECIFIC DELIVERY OF RNAS VIA TARGETED LIPID NANOPARTICLES |
16:30-17:00 | Assaf Zinger DISEASE DRIVEN THERAPEUTICS |
Short Pitches | |
17:00-17:35 | Short Pitches – 2 min (13 pitches) 1. Rotem Menachem 2. Elian Far 3. Kunal Pednekar 4. Alvja Mali 5. Saret Ortega-Galindo 6. Yael Hershkovitz-Pollak 7. Chen Chen 8. Kayal Yasmin 9. Robbin De Kruijf 10. Samvidha Das 11. Alena Kaltenbrunner 12. Siavash Mansouri 13. Poonam Sarode |
18:30-22:00 | Dinner + (Poster visits) |
|
|
Tuesday May 6, 2025 | |
Modeling and Modulation of the Tumor Microenvironment Chair: Assaf Zinger | |
09:00-09:30 | Twan Lammers IMAGING AND MODULATING THE TUMOR MICROENVIRONMENT TO IMPROVE NANOMEDICINE-BASED DRUG DELIVERY |
09:30-10:00 | Bruno Sarmento Multicomponent 3D Immunospheroid Models for Therapeutic Screening |
10:00-10:30 | Derk Jan de Groot PET IMAGING TO IMPROVE IMMUNE MODULATORY CANCER DRUG DEVELOPMENT |
Short talks selected from abstracts (12 min + 3 min discussion) | |
10:30-10:45 | Elisabetta Palamà AN INNOVATIVE IMMUNE-ON-CHIP PLATFORM FOR STUDYING TUMOR-IMMUNE INTERACTIONS AND EVALUATING NOVEL IMMUNOMODULATORY THERAPIES |
10:45-11:15 | Group photo & Tea/Coffee Break |
Spatial and Functional Profiling in the TME Chair: Twan Lammers | |
11:15-11:45 | Arne Östman IDENTIFICATION AND SPATIAL PROFILING OF NOVEL OUTCOME-ASSOCIATED SUBSETS OF CANCER-ASSOCIATED FIBROBLASTS |
11:45-12:15 | Peter Friedl IMPROVING MULTI-HIT MECHANISMS OF TUMOR CELL KILLING BY CTL IN THE PERTURBED TUMOR MICROENVIRONMENT |
Short talk selected from abstracts (12 min + 3 min discussion) | |
12:15-12:30 | Dor Breier CRISPR/CAS9 GENOME EDITING USING LIPID NANOPARTICLES FOR HEPATOCELLULAR CARCINOMA THERAPY |
12:30-12:45 | Rajinder Nandigama Spatial immune mapping of lung tumors: Shaping the immune terrain by KRAS and EGFR mutations |
12:45-13:00 | Rand Shibel Encapsulation of Exosomal Volatile Molecules for Modulating Immune Pathways |
13:00-14:15 | Lunch |
Nanomedicine for Targeted Therapy Chair: Roy van der Meel | |
14:15-14:45 | Natalie Artzi SUPERCHARGING IMMUNOTHERAPY THROUGH NANOTECHNOLOGY: CHEMICAL STRUCTURE MATTERS |
14:45-15:15 | Alberto Gabizon A FORMULATION OF LIPOSOME CO-ENCAPSULATED DOXORUBICIN AND ALENDRONATE MODULATES THE TUMOR MICROENVIRONMENT AND IMPROVES NANOMEDICINE-BASED CHEMO-IMMUNOTHERAPY |
Short Pitches | |
15:15-16:00 | Short Pitches – 2 min (15 pitches) 1. Elisa Raboni 2. Elisabetta Palamà 3. Annika Karger 4. Kiyan Musaie 5. Ahmed G. Hemden 6. Ana Arminan de Benito 7. Antoni Serrano Martí 8. Paul Manoukian 9. Remya Valoor 10. Ioanna Mitrentsi 11. Nikolas Mersinis 12. Ajinkya Manelkar 13. Diogo Coelho 14. Mirre M. Trines 15. Ekaterina Petrenko |
16:00-16:30 | Tea/Coffee Break |
Structural Nanomedicine Chair: Alberto Gabizon | |
16:30-17:00 | Maria J. Vicent POLYPEPTIDE-BASED NANOMEDICINES: ENHANCING TROPISM AND OVERCOMING BIOLOGICAL BARRIERS |
17:00-17:30 | Jai Prakash DESIGNING TARGETED NANOMEDICINE TO REPROGRAM THE TUMOR MICROENVIRONMENT |
Industrial Talks | |
17:30-17:45 | Miltenyi Biotec B.V. - Cillian Ross, Instrument Sales Specialist Imaging |
17:45-18:00 | Helix Biotech, Inc. - Graham Taylor, President |
18:30-20:30 | Dinner |
20:30-22:00 | Poster Presentation |
|
|
Wednesday May 7, 2025 | |
Tumor Evolution, Immunity and ECM Chair: Annamaria Gal | |
09:00-09:30 | Erik Sahai How the tumour microenvironment evolves and how it shapes tumour evolution |
09:30-10:00 | Oliver Pearce UNTANGLING EXTRACELLULAR MATRIX INTERACTIONS THAT CONTROL TUMOUR IMMUNITY |
10:00-10:30 | Thomas Cox TUMOR BIOMECHANICS ALTERS METASTATIC DISSEMINATION OF TRIPLE NEGATIVE BREAST CANCER VIA REWIRING FATTY ACID METABOLISM |
Short talks selected from abstracts (12 min + 3 min discussion) | |
10:30-10:45 | Deni van Schie MICROENVIRONMENTAL CONTRIBUTIONS TO THERAPY RESISTANCE AND STEMNESS IN ESOPHAGOGASTRIC ADENOCARCINOMA |
10:45-11:00 | Chiara Bastiancich OPTIMIZING GLIOBLASTOMA TREATMENT THROUGH LONGITUDINAL PROFILING OF THE POST-SURGICAL TUMOR MICROENVIRONMENT |
11:00-11:30 | Tea/Coffee Break |
Tumor Progression and Metastasis Chair: Dvir Aran | |
11:30-12:00 | Rajkumar Savai CHATTER OF THE LUNG TUMOR MICROENVIRONMENT: HOW CELLULAR CROSSTALK CONTRIBUTES TO CANCER PROGRESSION |
12:00-12:30 | Gertraud Orend TENASCIN-C MODULATING TUMOR IMMUNITY |
Short talk selected from abstracts (12 min + 3 min discussion) | |
12:30-12:45 | Andrea Vallés-Martí THE CLOSER, THE BETTER: INTRATUMORAL DELIVERY OF A THERMORESPONSIVE GEMCITABINE-LOADED HYDROGEL IN PRECLINICAL PDAC MODELS |
12:45-14:00 | Lunch |
Metastasis, Immunity, and Therapeutic Strategies Chair: Thomas Cox | |
14:00-14:30 | Jonathan Sleeman THE ID1/ID3 INHIBITOR X6632 SUPPRESSES CANCER INITIATION, GROWTH AND METASTASIS BY TARGETING BOTH TUMOR CELLS AND THE TUMOR-ASSOCIATED VASCULATURE
|
14:30-15:00 | Yuval Shaked Brain metastasis in the era of immunotherapy |
15:00-15:30 | Dvir Aran FRAMEWORK FOR ANALYZING CELLULAR DYNAMICS IN THE TUMOR MICROENVIRONMENT REVEALS TARGETABLE PATTERNS FOR IMMUNOMODULATION |
15:30-16:00 | Annamaria Gal PLASTICITY OF TUMOUR ASSOCIATED MACROPHAGES IN PULMONARY METASTASIS FROM MELANOMA |
16:00-16:30 | Poster Prize announcement & end of the conference |
